Literature DB >> 15198446

Medical and cognitive outcome in children with traumatic brain injury.

Craig G N Campbell1, Sally M Kuehn, Pauline M P Richards, E Ventureyra, James S Hutchison.   

Abstract

BACKGROUND: Head injury is an important cause of morbidity and mortality in pediatrics. Comprehensive studies on outcome are scarce despite significant clinical concern that multiple areas of functioning may be impaired following moderate to severe head injury. The literature suggests that sequelae include not only medical problems but also impairments in cognitive functioning.
METHODS: A retrospective medical and psychology chart review of patients, age 1-18 years, admitted to the Children's Hospital of Eastern Ontario with moderate (Glasgow Coma Scale [GCS] 9-12) or severe head injury (GCS < or = 8) from November 1, 1993 until December 31, 1998 was conducted. Correlations were performed between medical variables (i.e., GCS, Pediatric Risk of Mortality [PRISM] III score, duration of ICU and hospital stay) and measures of intelligence and memory functioning.
RESULTS: Eighty-three children age 1 to 18 were included. Seventy percent of the children were classified as having a severe head injury. There was a mortality rate of thirteen percent. Younger age at injury, lower GCS, and higher PRISM III scores predicted higher mortality. Medical complications were documented systematically. Forty-four patients underwent at least one cognitive assessment and 17 of these children had intelligence testing at three points in time: baseline (< four months), early recovery (five to 15 months) and follow-up (16 to 38 months). The mean intelligence and memory scores fell within the average range at the latest point in follow-up. For those children who underwent three serial assessments, the mean verbal and performance IQ fell within the low average range at baseline improving significantly to fall within the average range by early recovery. Continued improvements were apparent in verbal memory beyond early recovery, with the mean obtained at follow-up falling within 1 SD of the normative mean. Despite the return to normal ranges for the group means the proportion of scores falling below 1.5 standard deviations from the mean was greater than population norms for verbal IQ, performance IQ and verbal memory. Lower GCS scores and longer duration of stay in ICU or hospital were predictive of lower nonverbal intelligence. Lower GCS was also predictive of lower visual memory scores.
CONCLUSIONS: This study describes a population of Canadian children who suffered moderate or severe traumatic brain injury. Initial GCS was the best predictor of mortality and cognitive outcome. These children demonstrated a temporal improvement in intelligence and memory functioning, with their mean performance on these cognitive measures falling within the average range at 16 to 38 months postinjury, although there was considerable variability in the outcomes between individuals.

Entities:  

Mesh:

Year:  2004        PMID: 15198446     DOI: 10.1017/s0317167100053853

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  10 in total

1.  Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury.

Authors:  Linda Papa; Linnet Akinyi; Ming Cheng Liu; Jose A Pineda; Joseph J Tepas; Monika W Oli; Wenrong Zheng; Gillian Robinson; Steven A Robicsek; Andrea Gabrielli; Shelley C Heaton; H Julia Hannay; Jason A Demery; Gretchen M Brophy; Joe Layon; Claudia S Robertson; Ronald L Hayes; Kevin K W Wang
Journal:  Crit Care Med       Date:  2010-01       Impact factor: 7.598

2.  Glasgow Coma Scale Score in Pediatric Patients with Traumatic Brain Injury; Limitations and Reliability.

Authors:  Fariborz Ghaffarpasand; Ali Razmkon; Maryam Dehghankhalili
Journal:  Bull Emerg Trauma       Date:  2013-10

3.  Plasma D-dimer as a Prognostic Marker in ICU Admitted Egyptian Children with Traumatic Brain Injury.

Authors:  Hala Mohamed Amin Foaud; John Rene Labib; Hala Gabr Metwally; Khaled Mohamed Abd El-Twab
Journal:  J Clin Diagn Res       Date:  2014-09-20

4.  Prognostic factors of acute neurological outcomes in infants with traumatic brain injury.

Authors:  Shunsuke Amagasa; Satoshi Tsuji; Hikoro Matsui; Satoko Uematsu; Takashi Moriya; Kosaku Kinoshita
Journal:  Childs Nerv Syst       Date:  2017-12-16       Impact factor: 1.475

5.  Factors associated with hemispheric hypodensity after subdural hematoma following abusive head trauma in children.

Authors:  Kimberly A Foster; Matthew J Recker; Philip S Lee; Michael J Bell; Elizabeth C Tyler-Kabara
Journal:  J Neurotrauma       Date:  2014-06-12       Impact factor: 5.269

6.  Risk factors for mortality in children with abusive head trauma.

Authors:  Steven L Shein; Michael J Bell; Patrick M Kochanek; Elizabeth C Tyler-Kabara; Stephen R Wisniewski; Kenneth Feldman; Kathi Makoroff; Philip V Scribano; Rachel P Berger
Journal:  J Pediatr       Date:  2012-05-11       Impact factor: 4.406

7.  Traumatic brain injury in pediatric age group; predictors of outcome in Pediatric Intensive Care Unit.

Authors:  Hm Kamal; Aa Mardini; Bokhary Mm Aly
Journal:  Libyan J Med       Date:  2007-06-01       Impact factor: 1.657

8.  Isolated traumatic head injury in children: Analysis of 276 observations.

Authors:  Mabrouk Bahloul; Hedi Chelly; Anis Chaari; Imen Chabchoub; Sondes Haddar; Leila Herguefi; Hassen Dammak; Chokri Ben Hamida; Hichem Ksibi; Hatem Kallel; Noureddine Rekik; Mounir Bouaziz
Journal:  J Emerg Trauma Shock       Date:  2011-01

9.  Outcome analysis and outcome predictors of traumatic head injury in childhood: Analysis of 454 observations.

Authors:  Mabrouk Bahloul; Anis Chaari; Imen Chabchoub; Fatma Medhyoub; Hassen Dammak; Hatem Kallel; Hichem Ksibi; Sondes Haddar; Noureddine Rekik; Hedi Chelly; Mounir Bouaziz
Journal:  J Emerg Trauma Shock       Date:  2011-04

10.  Memory and the hippocampal formation following pediatric traumatic brain injury.

Authors:  Dana DeMaster; Chad Johnson; Jenifer Juranek; Linda Ewing-Cobbs
Journal:  Brain Behav       Date:  2017-11-02       Impact factor: 2.708

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.